In information obtained through a Freedom of Information Act lawsuit filed by Judicial Watch, Pfizer’s own study revealed that lipid nanoparticles, a key component of their COVID vaccines, stick to your organs, especially the liver, adrenal glands, spleen, and ovaries.
Judicial Watch today announced that it had received 466 pages of records (pdf below) from the Department of Health and Human Services (HHS) relating to biodistribution studies and related data for the COVID-19 vaccines, which show that lipid nanoparticles (LNPs), a key component of the vaccines developed by Pfizer/BioNTech, were found outside the injection site, primarily in the liver, adrenal glands, spleen, and ovaries of test animals, 8 to 48 hours after injection.
LNPs are used as a delivery mechanism in Pfizer/BioNTech’s mRNA-based COVID vaccine. Acuitas Therapeutics LNP technology is used in COMIRNATY, the Pfizer/BioNTech COVID-19 vaccine, according to a press release issued by Pfizer on January 10, 2022.
Johnson & Johnson relied on studies showing that vaccine DNA particles and injected virus particles were still present in test animals months after injection, according to 663 pages of records obtained from HHS regarding biodistribution studies and related data for COVID-19 vaccines, which show that Johnson & Johnson relied on studies showing that vaccine DNA particles and injected virus particles were still present in test animals months after injection.
According to the data, Johnson & Johnson did not include tests of the spike protein encoded in the J&J vaccination in its submission to the FDA for approval of its COVID vaccine.
A method of tracking where compounds of interest go in an experimental animal or human subject is called biodistribution.
The records were obtained through a Freedom of Information Act (FOIA) lawsuit (Judicial Watch v. U.S. Department of Health and Human Services (No. 1:21-cv-02418)) filed by Judicial Watch after the Food and Drug Administration, the Centers for Disease Control and Prevention, and the National Institute for Allergy and Infectious Disease failed to respond to a June 8, 2021, FOIA request for:
Access to biodistribution studies and related data for the Pfizer, Moderna, and Johnson & Johnson vaccines used to treat and/or prevent SARS-CoV-2 and/or COVID-19.
In a section titled “Safety Pharmacology,” the report notes, “No safety pharmacology studies were conducted with BNT162b2 [the BioNTech vaccine] as they are not considered necessary for the development of vaccines according to the WHO guideline (WHO, 2005).”
The Pfizer records also include a report approved in February 2021 on the animal trials on the distribution of the Pfizer COVID vaccine in rat subjects. “Nonclinical studies evaluating pharmacodynamic drug interactions with BNT162b2 were not conducted as they are generally not considered necessary to support the development and licensure of vaccine products for infectious diseases (WHO, 2005),” it says under “Pharmacodynamic Drug Interactions.”